The Drug Regulatory Authority of Pakistan (DRAP) has launched an online licensing and registration system for alternative medicines and health products, bringing the manufacture, registration and sale of these products under formal legal control, 24NewsHD reported on Wednesday.
DRAP announced the launch on 17 November 2026 under the Alternative Medicines and Health Products Rules, 2026. The rules were notified a day earlier through S.R.O. 2117(I)/2026, while the fee schedule for alternative medicines and health products was notified through S.R.O. 2118(I)/2026 on the same day.
The new system covers alternative medicines and health products, including herbal, homeopathic and nutraceutical products. Manufacturers and importers will now have to register their products and obtain licences through DRAP’s online portal before they can be made or sold in the country. DRAP has also published tutorials on its website to guide applicants through the online process.
The move formalises oversight of a large and fast-growing market. Vitamins, minerals, herbal products and probiotics have fallen under DRAP’s enlistment rules since 2014, when the authority began requiring products to be enlisted before sale. In October, DRAP moved to bring eight categories of everyday health products — including vitamins and dietary supplements, medicated soaps and shampoos, and specialised infant milk — under tighter regulatory oversight, with mandatory registration, approval and quality-control checks.
The tighter control is aimed at ensuring that products carrying medicinal or therapeutic claims meet prescribed standards of quality, safety and efficacy, and at curbing the sale of unregistered and substandard products. DRAP has also been expanding its wider regulatory net: since 9 October 2026, manufacturers and importers have been required to print a 2D barcode with a unique serial number on every pack of medicine under the pharmaceutical track and trace system, so that customers can check a product and its price through the authority’s Mehfooz Dawa app.
DRAP regulates pharmaceutical products under the Drugs Act 1976 and the DRAP Act 2012. All drugs intended for manufacture, sale or export must be registered with the authority, and every manufacturing facility must hold a drug manufacturing licence issued after satisfactory good manufacturing practice inspection.
The authority has not stated a deadline in its announcement for existing manufacturers and sellers of alternative medicines to complete their registration under the new rules.

Leave a Reply